ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,417Medicare Part D Prescriptions Filled, Including Refills

Rank: 36 out of 395

$629K Total Retail Price of All Prescriptions

Rank: 44 out of 395

749 Patients Receiving at Least One Drug in Part D
73% Patients 65 Years and Older
39% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Nevada
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

8% of this provider’s 749 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

17% of this provider’s 749 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Nevada
LISINOPRIL 523 409 118 1 1
LEVOTHYROXINE SODIUM 450 352 95 2 3
HYDROCODONE-ACETAMINOPHEN 426 305 114 S3 3 5
AMLODIPINE BESYLATE 391 310 84 4 4
SIMVASTATIN 379 313 89 5 2
METFORMIN HCL 279 221 62 6 7
ALPRAZOLAM 248 131 57 B 7 14
ATORVASTATIN CALCIUM 231 195 70 8 8
OMEPRAZOLE 228 160 61 9 6
ATENOLOL 205 164 44 10 15
FUROSEMIDE 194 140 58 11 10
ZOLPIDEM TARTRATE 181 77 49 12 18
METOPROLOL TARTRATE 177 114 36 13 11
LOSARTAN POTASSIUM 177 139 35 13 9
HYDROCHLOROTHIAZIDE 168 115 38 15 13
WARFARIN SODIUM 163 89 28 16 19
CLOPIDOGREL 163 144 34 16 21
PRAVASTATIN SODIUM 147 131 35 18 16
PANTOPRAZOLE SODIUM 145 98 42 19 35
OXYCODONE HCL-ACETAMINOPHEN 143 55 23 S2 20 48
GABAPENTIN 137 72 42 21 12
POTASSIUM CHLORIDE 128 86 35 22 22
TEMAZEPAM 123 98 32 B 23 33
TRIAMCINOLONE ACETONIDE 119 83 60 24 100
MONTELUKAST SODIUM 117 85 27 25 71
CARISOPRODOL 113 42 24 R 26 65
CLONIDINE HCL 112 93 23 27 60
LISINOPRIL-HYDROCHLOROTHIAZIDE 111 83 34 28 27
LOVASTATIN 110 110 24 29 17
ALLOPURINOL 109 68 28 30 29
TAMSULOSIN HCL 104 99* 27 31 24
LEVOFLOXACIN 99 73 86 32 92
TRAMADOL HCL 97 92* 37 33 30
FLUTICASONE PROPIONATE 90 54 41 34 28
SERTRALINE HCL 89 53 20 35 31
GLYBURIDE 85 80* 17 R 36 117
LORAZEPAM 85 63 17 B 36 43
FENOFIBRATE* 82 44 14 38 49
DIAZEPAM 79 39 26 B 39 68
AZITHROMYCIN 79 51 72 39 38
TRAZODONE HCL 78 12 15 41 41
MIRTAZAPINE 77 34 12 42 93
DIOVAN 73 47 15 43 80
METOPROLOL SUCCINATE 70 50 21 44 25
VENLAFAXINE HCL ER 70 44 15 44 132
FLUOXETINE HCL 65 27 16 46 44
HYDRALAZINE HCL 65 43 18 46 61
GLIMEPIRIDE 65 60* 13 46 40
SYNTHROID 64 59* 18 49 39
DONEPEZIL HCL 63 58* 15 50 36
ALENDRONATE SODIUM 63 49 14 50 20
CITALOPRAM HBR 62 41 21 52 26
FINASTERIDE 58 53* 11 53 58
AMITRIPTYLINE HCL 57 17 14 R 54 86
QUETIAPINE FUMARATE 57 <11 <11 A 54 79
NEXIUM 57 43 13 54 89
METHYLPREDNISOLONE 57 44 48 54 82
VENLAFAXINE HCL 56 42 13 58 299
GLIPIZIDE 55 55 13 59 32
NAPROXEN 55 50* 18 59 99
LANTUS SOLOSTAR 53 31 16 61 64
OXYCODONE HCL 51 15 12 S2 62 42
KLOR-CON 10 50 <11 <11 63 114
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 26, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.